Ipsen’s latest R&D alliance brings novel T cell-activating drugs for cancer

Ipsen’s latest R&D alliance brings novel T cell-activating drugs for cancer

On the heels of reaching an acquisition agreement that brings Ipsen a commercialized follicular lymphoma drug, the Paris-based drugmaker is expanding its reach in cancer through a licensing deal that takes it into a new area of ​​drug research. Ipsen is collaborating with Marengo Therapeutics, a startup with technology that activates T cells and gets … Read more

Lisa Health launches digital menopause app with Mayo Clinic

Lisa Health launches digital menopause app with Mayo Clinic

Each day in the US, about 6,000 women reach menopause. More than 75% of these women experience uncomfortable symptoms like hot flashes, which usually last between seven and nine years. Oftentimes, women feel like there are no treatments for the physical and emotional changes they experience during this life stage, so they opt to silently … Read more

AmeriHealth New Jersey, Thyme Care partner to help members through cancer journey

AmeriHealth New Jersey, Thyme Care partner to help members through cancer journey

Health insurance company AmeriHealth New Jersey is partnering with Thyme Care, an oncology care management company, to help its members navigate cancer diagnoses. The new alliance starts on Jan. 1, 2023. Thyme Care, based in Nashville and founded in 2020, focuses on assisting patients through their cancer journey by providing education and support on their … Read more

Home care does not always require a traditional home setting, experts say

Home care does not always require a traditional home setting, experts say

Earlier this year, a patient of an Oklahoma hospital had been in and out of the emergency department six times in the previous 10 days for treatment of a severe bone infection. But because he lacked trust in the healthcare system, he didn’t want to stay in the hospital. So he was offered care in … Read more

Former Hims and Hers exec launches pediatric telehealth startup backed by Sequoia, Lux

Former Hims and Hers exec launches pediatric telehealth startup backed by Sequoia, Lux

As a mother of two young boys, Ellen DaSilva said she and other parents in the US feel “generally feel pretty underserved by the existing pediatric care infrastructure.” She and her husband have waited hours in the emergency room to obtain answers to simple questions about their children’s health, and they sometimes wait days for … Read more

Clinical trial sponsors need to take into consideration pandemic burnout

Clinical trial sponsors need to take into consideration pandemic burnout

Never before have clinical researchers had more options at their fingertips when designing a study. As technology leaps ahead, companies are sending more notifications, collecting larger amounts of data, and adding more apps, wearables, and ePROs to studies. But researchers need to be considerate about the fact that many potential participants are dealing with burnout, … Read more

Aiming to bring drug combos into earlier lines of cancer therapy, IDRx lands $122M

Aiming to bring drug combos into earlier lines of cancer therapy, IDRx lands 2M

A precision medicine is only as good as its target. While targeted therapies now address many types of cancer, tumors still frequently develop mutations that help them escape a drug. One strategy to address tumor escape is combining different cancer drugs. Biotech startup IDRx aims to use scientific knowledge of tumor biology to develop new … Read more

Lessons learned from prison and dialysis while trying to prevent the pain, loss and cost of kidney diseases

Lessons learned from prison and dialysis while trying to prevent the pain, loss and cost of kidney diseases

Cardiology has the heart attack, oncology has the fateful diagnosis date, but there is no “kidney attack” to serve as a traumatic wake-up call for those at risk of kidney diseases. There is no event to urgently change someone’s point of view; “From this moment forward, you will pay attention to your kidneys and do … Read more

Digital transformation: Reimagining clinical trial management

Digital transformation: Reimagining clinical trial management

Even before Covid-19 disrupted the traditional model for clinical trials, researchers were harnessing the power of technology to make trials more accessible and improve data collection. The movement had coalesced under the banner of decentralized clinical trials, or DCTs, which leverage technology and other non-traditional approaches to monitor patients and gather data without limits on … Read more

With ‘bold experiment’ in drug pricing, Arcutis aims to stand out in plaque psoriasis

With ‘bold experiment’ in drug pricing, Arcutis aims to stand out in plaque psoriasis

FDA approval of a new Arcutis Biotherapeutics drug for plaque psoriasis enables the company to roll out a strategy it believes will win over both payers and patients—lower prices. Arcutis set an $825 wholesale price for each tube of its topical drug, roflumilast, which will be marketed under the brand name “Zoryve.” By comparison, Dermavant … Read more